Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

The UK’s new industrial strategy signals a decisive shift toward state-backed innovation, investment, and regulatory reform.

On July 24, 2025, the Federal Trade Commission (“FTC”) and the U.S. Department of Justice (“DOJ”) convened the second of ...

Experts from the life sciences industry have shared key insights into how healthcare innovation is changing and the next wave of medicines.The ...

Amgen Inc. (NASDAQ:AMGN) is on the hunt for its next breakthrough drug— a common pursuit among pharmaceutical companies ...

Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

In addition to telling time, smartwatches can track your steps, heart rate, blood pressure and sleeping patterns. Now, a smartwatch has helped search and rescue teams locate a ...

Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...